Cantitate/Preț
Produs

Manual of Antisense Methodology

Editat de Gunther Hartmann, Stefan Endres
en Limba Engleză Hardback – 31 mai 1999
In the past few years, antisense methodology has moved from in vitro studies to in vivo studies and first human trials. While the basic concept of antisense technology is simple, the methodological problems associated with its use are numerous and complex. Antisense- based methods have proven to be a field of research where careful attention to experimental protocols and appropriate controls is necessary.
The Manual of Antisense Methodology emphasizes the application of antisense oligonucleotides, and is a guide for the identification of antisense and non-antisense effects in different experimental settings. The work is organized into three sections: antisense application in vitro, antisense application in vivo (animal models) and finally, clinical antisense studies. Where at all possible, the methods are described in sufficient detail to allow reproduction of a given experiment.
The Manual of Antisense Methodology will be of interest to researchers in immunology, cancer research, pharmacology and internal medicine; and physicians conducting clinical studies in these fields.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 90453 lei  6-8 săpt.
  Springer Us – 12 oct 2012 90453 lei  6-8 săpt.
Hardback (1) 91028 lei  6-8 săpt.
  Springer Us – 31 mai 1999 91028 lei  6-8 săpt.

Preț: 91028 lei

Preț vechi: 111009 lei
-18%

Puncte Express: 1365

Preț estimativ în valută:
16093 19129$ 13963£

Carte tipărită la comandă

Livrare economică 12-26 martie


Specificații

ISBN-13: 9780792385394
ISBN-10: 079238539X
Pagini: 205
Ilustrații: XIII, 205 p.
Dimensiuni: 156 x 234 x 14 mm
Greutate: 0.49 kg
Ediția:1999 edition
Editura: Springer Us
Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

I: The chemistry of antisense oligonucleotides.- 1. Chemical synthesis and purification of phosphorothioate antisense oligonucleotides.- 2. How to choose optimal antisense targets in an mRNA.- II: Antisense application in vitro.- 3. How to characterize and improve oligonucleotide uptake into leukocytes.- 4. Strategies for targeted uptake of antisense oligonucleotides in hepatocytes.- 5. How to exclude immunostimmulatory and other nonantisense effects of antisense oligonucleotides.- 6. Testing antisense oligonucleotides in controlled cell culture assays.- 7. Inhibition of TNF synthesis by antisense oligonucleotides.- 8. Inhibition of IGF-1 receptor expression by antisense oligonucleotides in vitro and in vivo.- III: Antisense application in vivo.- 9. How to test antisense oligonucleotides in animals.- 10. Lipid-based carriers for the systemic delivery of antisense drugs.- 11. Designing a clinical antisense study.

Notă biografică

Gunther Hartmann, M.D. is a clinical and research fellow at the Division of Clinical Pharmacology, University of Munich.Stefan Endres, M.D. is an internist with subspecialties in gastroenterology and intensive care medicine. He is Chief of the Division of Clinical Pharmacology of the medical faculty at the University of Munich.